Aspergillus-mediated allergic airway inflammation is triggered by dendritic cell recognition of a defined spore morphotype

Houlder, Emma L., Gago, Sara, Vere, George, Furlong-Silva, Julio, Conn, Daniel, Hickey, Emer, Khan, Saba, Thomson, Darren, Shepherd, Mark W., Lebedinec, Ressa, Brown, Gordon D., Horsnell, William, Bromley, Mike, MacDonald, Andrew S. and Cook, Peter C. 2025. Aspergillus-mediated allergic airway inflammation is triggered by dendritic cell recognition of a defined spore morphotype. Journal of Allergy and Clinical Immunology 155 (3) , pp. 988-1001. 10.1016/j.jaci.2024.10.040

PDF - Published Version Available under License Creative Commons Attribution. Download (2MB)

Abstract

Background Exposure to fungi, especially Aspergillus fumigatus, can elicit potent allergic inflammation that triggers and worsens asthmatic disease. Dendritic cells (DCs) initiate allergic inflammatory responses to allergic stimuli. However, it is unclear if Af spores during isotropic growth (early spore swelling) can activate DCs to initiate allergic responses or if germination is required. This lack of basic understanding of how Af causes disease is a barrier to developing new treatments. Objective We sought to show that a precise Af morphotype stage during spore swelling can trigger DCs to mediate allergic inflammatory responses and ascertain if antifungal therapeutics can be effective at suppressing this process. Methods We used an Af strain deficient in pyrimidine biosynthesis (ΔpyrG) to generate populations of Af spores arrested at different stages of isotropic growth (swelling) via temporal removal of uracil and uridine from growth media. These arrested spore stages were cultured with bone marrow–derived DCs (BMDCs), and their activation was measured via flow cytometry and ELISA to examine which growth stage was able to activate BMDCs. These BMDCs were then adoptively transferred into the airways to assess if they were able to mediate allergic inflammation in naïve recipient mice. Allergic airway inflammation in vivo was determined via flow cytometry, ELISA, and real-time quantitative PCR. This system was also used to determine if antifungal drug (itraconazole) treatment could alter early stages of spore swelling and therefore BMDC activation and in vivo allergic inflammation upon adoptive transfer. Results We found that Af isotropic growth is essential to trigger BMDC activation and mediate allergic airway inflammation. Furthermore, using time-arrested Af stages, we found that at least 3 hours in growth media enabled spores to swell sufficiently to activate BMDCs to elicit allergic airway inflammation in vivo. Incubation of germinating Af with itraconazole reduced spore swelling and partially reduced their ability to activate BMDCs to elicit in vivo allergic airway inflammation. Conclusion Our results have pinpointed the precise stage of Af development when germinating spores are able to activate DCs to mediate downstream allergic airway inflammation. Furthermore, we have identified that antifungal therapeutics partially reduced the potential of Af spores to stimulate allergic responses, highlighting a potential mechanism by which antifungal treatment might help prevent the development of fungal allergy.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Publisher:	Elsevier
ISSN:	0091-6749
Date of First Compliant Deposit:	12 November 2025
Date of Acceptance:	31 October 2024
Last Modified:	12 Nov 2025 11:15
URI:	https://orca.cardiff.ac.uk/id/eprint/182334

Actions (repository staff only)

Edit Item